Flumetazon

Flumetazon
Klinički podaci

Drugs.com	Monografija
Identifikatori
CAS broj	2135-17-3^Y
ATC kod	D07AB03 (WHO), D07XB01 (combinations), QH02AB90
PubChem	CID 16490
UNII	LR3CD8SX89^Y
KEGG	D04208^Y
ChEMBL	CHEMBL1201392^Y
Sinonimi	(6S,8S,9S,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
Hemijski podaci
Formula	C₂₂H₂₈F₂O₅
Molarna masa	410,452
SMILES C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
InChI InChI=1S/C22H28F2O5/c1-11-6-13-14-8-16(23)15-7-12(26)4-5-19(15,2)21(14,24)17(27)9-20(13,3)22(11,29)18(28)10-25/h4-5,7,11,13-14,16-17,25,27,29H,6,8-10H2,1-3H3/t11-,13+,14+,16+,17+,19+,20+,21+,22+/m1/s1^Y Key:WXURHACBFYSXBI-GQKYHHCASA-N^Y

Flumetazon je organsko jedinjenje, koje sadrži 22 atoma ugljenika i ima molekulsku masu od 410,452 Da.

Osobine

Osobina	Vrednost
Broj akceptora vodonika	5
Broj donora vodonika	3
Broj rotacionih veza	2
Particioni koeficijent^[1] (ALogP)	1,5
Rastvorljivost^[2] (logS, log(mol/L))	-4,1
Polarna površina^[3] (PSA, Å²)	94,8

^ Ghose, A.K.; Viswanadhan V.N. & Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A. 102: 3762—3772. doi:10.1021/jp980230o.
^ Tetko IV, Tanchuk VY, Kasheva TN, Villa AE (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488—1493. PMID 11749573. doi:10.1021/ci000392t.
^ Ertl P.; Rohde B.; Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714—3717. PMID 11020286. doi:10.1021/jm000942e.

Hardman JG, Limbird LE, Gilman AG (2001). Goodman & Gilman's The Pharmacological Basis of Therapeutics (10. изд.). New York: McGraw-Hill. ISBN 0071354697. doi:10.1036/0071422803.
Thomas L. Lemke; David A. Williams, ур. (2007). Foye's Principles of Medicinal Chemistry (6. изд.). Baltimore: Lippincott Willams & Wilkins. ISBN 0781768799.

Mineralokortikoidi
(3-on, 4-en,
bez fg u 16)

Glukokortikoid
(3-on, 4-en,
11-FG,
17-hidroksi)

Pregnen	Kortizon
Pregnendion (+20-one)	Hidrokortizon/kortizol^# Hidrokortizon aceponat Hidrokortizon buteprat Hidrokortizon butirat Budezonid Ciklezonid Deflazakort Medrizon Tiksokortol halogenisan u 6: Kloprednol halogenisan, sa fg u 16: Halcinonid
Pregnadien (+1-en)	Rimeksolon halogenisan, sa fg u 16: Flunizolid Triamcinolon Amcinonid Fluocinolon acetonid Fluocinonid
Pregnadiendiol (+21-hidroksi)	Prednizon Meprednizon Triamcinolon acetonid halogenisan u 9: Fluorometolon halogenisan, sa fg u 16: Fluokortolon Klokortolon Diflukortolon Fluokortin Desoksimetazon
Pregnadientriol (+11-hidroksi)	Prednizolon^# Metilprednizolon Metilprednizolon aceponat Prednikarbat Predniliden Dezonid halogenisan: Fluprednizolon Difluprednat Fluperolon acetat halogenisan, sa fg u 16: Deksametazon^# Betametazon Klobetazol propionat Klobetazon Diflorazon Halometazon Ulobetazol Beclometazon Parametazon Alklometazon Fluklorolon Flumetazon Flupredniden
Pregnatrien (+2-en)	Kortivazol
Androsten	halogenisan, sa fg u 16: Flutikazon Flutikazon propionat Flutikazon furoat
Drugi/negrupisani	halogenisan: Loteprednol halogenisan, sa fg u 16: Fludroksikortid Formokortal Mometazon furoat